Positive Data Reported in a Multinational Clinical Trial Investigating New Treatment of Niemann-Pick disease Type C

A multinational clinical trial of for the treatment of Niemann-Pick disease Type C (NPC) demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning, and quality of life in both primary and topline secondary endpoints for both pediatric and adult patients with NPC.